Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy
Authors
Keywords
Hereditary transthyretin amyloidosis, quality of life, Autonomic neuropathy, Orthostatic hypotension
Journal
CLINICAL AUTONOMIC RESEARCH
Volume 29, Issue S1, Pages 25-31
Publisher
Springer Science and Business Media LLC
Online
2019-09-10
DOI
10.1007/s10286-019-00624-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis)
- (2018) Alejandra Gonzalez-Duarte CLINICAL AUTONOMIC RESEARCH
- Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers
- (2018) Eve Piekarski et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension
- (2017) Christopher H. Gibbons et al. JOURNAL OF NEUROLOGY
- Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years
- (2017) Jonas Wixner et al. Expert Review of Gastroenterology & Hepatology
- Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis
- (2016) David Hamon et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- “Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy
- (2016) Isabel Conceição et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Clinical measures in transthyretin familial amyloid polyneuropathy
- (2016) Teresa Coelho et al. MUSCLE & NERVE
- Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy
- (2016) Massimo Russo et al. NEUROMUSCULAR DISORDERS
- Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments
- (2015) Yoshiki Sekijima JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Liver transplantation in transthyretin amyloidosis: Issues and challenges
- (2015) Andreia Carvalho et al. LIVER TRANSPLANTATION
- Erectile dysfunction is a strong predictor of poor quality of life in men with Type 2 diabetes mellitus
- (2014) L. S. Malavige et al. DIABETIC MEDICINE
- Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy
- (2014) Etta J. Vinik et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- THAOS: Gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease
- (2014) Jonas Wixner et al. Orphanet Journal of Rare Diseases
- Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
- (2013) Teresa Coelho et al. JOURNAL OF NEUROLOGY
- COMPASS 31: A Refined and Abbreviated Composite Autonomic Symptom Score
- (2012) David M. Sletten et al. MAYO CLINIC PROCEEDINGS
- Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
- (2012) T. Coelho et al. NEUROLOGY
- Familial amyloid polyneuropathy
- (2011) Violaine Planté-Bordeneuve et al. LANCET NEUROLOGY
- Bladder dysfunction in peripheral neuropathies
- (2011) Ahmet Z. Burakgazi et al. MUSCLE & NERVE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More